FDA Posts
Jun 01, 2026
EU adopts roadmap to phase out animal testing
The European Commission published a roadmap covering 15 domains, including chemicals, pesticides, pharmaceuticals, and food additives, with over 30 key recommendations to move toward non-animal methods. RAPS
May 30, 2026
FDA targets oncology drug development
The FDA proposed targeted guidance to reduce animal testing in oncology, aiming to streamline the drug development process without compromising patient safety. RAPS
Mar 18, 2026
FDA issues draft guidance on New Approach Methodologies
The FDA opened the door to organ-on-chip and AI-based methods in drug development. By early 2026, FDA reported 151 NAM-related tools in the qualification pipeline. IntuitionLabs
Nov 11, 2025
UK backs human in-vitro models with new funding
The MRC, Innovate UK, and the Wellcome Trust committed funding to advance organ-on-chip models, with 5 UK teams focusing on liver, brain, cancer, pain and blood vessel disease models. HM Revenue and Customs
